Table: begin end state 1 1614 non-cytoplasmic
Input: >201733 MALKDAMPSVLLENVVSLIHAKVPNSQAKQVEQFATCLYAHMSKDDLNARNDSDLYGAVL SLWNALNKTPKGETHLRVFNPSQSKHGWQSTHSIIEVIQPDMPFLVDSVGMALNRMGITA HVMLHTPLAIERSAQEVTKVTYLNQSPDSTEHVAVFLIEIDRQSSTADIKALEREIQSVL ADVAASVNDWGAMSAKLSETIKELPKRPFPGEKQELEEAINFLTYLNNHHFTLLGYRQYD LKRVEGDVELVPNIASSLGLMNKHHKTQPEQGLLLSSFSDSARKEALDHSLLILTKSSAK SRVHRPAYVDYIGIKRFDKKGNVIGEDRFIGLYASNVYNRSPREIPLLNEKVQRVLDRSG LTPRSHDYKALLNILENLPRDELIQANVDDLAHTAHGVLEMQDRDKLKLFVRKDGFGRFL SCLVYVSKDRYNTKLRQDTQRILAQHFNSKEDVEFTTYFSESTLARTHYIVKVDNNNMDV DVAAIENNLIEAARSWEDKLNTALNNALGEEAGTHLMKRYANAFEQSYKEDVLPSSAVVD MQQLEALDDEHKLGMLFYQPQEAALNDNKVRLKLFHKDEPIHLSDVLPMLENFGLRVINE RPYEVTTADGSTFWILDFLMTVKVVNTDNIADSQDRFQTALSQVWQKKLEDDGFNRIILA SGLTGREVSVLRAYAKYMRQIDATFSQAYIEETFGRYPQIADLLVKMFIRKFNPKLKTRT LGKFMEQINLRLDEVSSLDDDRIIRRYLDLINATLRTNFYQLDAKGESKSYISFKFMPSL IPEMPRPLPKFEIFVYSPRVEGVHLRYGKVARGGLRWSDRREDFRTEVLGLVKAQQVKNT VIVPVGAKGGFVCKQLPTEGGREAFFTEGQECYRIFIRALLDITDNILNGEIVHPVDVVR HDEDDPYLVVAADKGTATFSDIANSISLEYNFWLGDAFASGGSNGYDHKKMGITAKGGWE SVKRHFREVGIDCQTTDFTCLGIGDMAGDVFGNGMLLSKHTKLVAAFNHMHIFIDPNPDA ATSYEERARLFALPRSSWEDYNSKLISKGGGVFLRSSKSIPLSAEMKQMLGTEKISMTPT EMMKELLKMPVDLIWNGGIGTYVKSSRETNAEVGDRANDALRVNGRELRAKIVGEGGNLG CTQLGRIEYAANGGRINTDFVDNVGGVDCSDNEVNIKILLNAMVTEGELTLKQRNRLLGE MTEEVGEIVLQDCKDQTRTISVTQVRGAEQLKEQIRFIQYLEKEGKLDRALEFLPSEEEL TERLANGRALTRPELSVLVAYAKMVLKEQLLTPEITEDTLLSQLLIAYFPKKLQELYSAR MVTHPLRGEIIATSLANELVNDMGLNFVQRMQDETGASVADAAICYTMAREVFGLAELTK SITDLNGIVPAVVQGEMLHQLRRNMRRACRWFLRHRNRSWSIEQTVAFFKPVFEQLKANV HSYLAEEEAAGIQAEINALIKENVPQDVASTVANMSTLFSTLDIAQIAQAEEKTVALVAE TYFKLGARVELHWFLEQISAQPVTNHWQALARAAFREELDWQQRALTSVVLRTCSATCNA QSVISLWIETNQALLERWFHMLADFKTSQNHEFAKFSVALRELNLLILHCEGQK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server